Showing results (3091-3100 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 22, 2009
Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancerBhuvaneswari Ramaswamy, Ewa Mrozek, John Philip Kuebler, et al.
Investigational New Drugs|February 11, 2010
A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancerFranklin M Chu, Joel Picus, Paula M Fracasso, et al.
Investigational New Drugs|February 20, 2010
Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7Ariane Chan, Peter M Andreae, Peter T Northcote, et al.
Investigational New Drugs|February 20, 2010
Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanismMirth T Hoyt, Rahul Palchaudhuri, Paul J Hergenrother
Investigational New Drugs|February 25, 2010
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junctionJuan W Valle, Anne Armstrong, Chris Newman, et al.
Investigational New Drugs|September 7, 2016
Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumorsHirofumi Mukai, Ken Kato, Taito Esaki, et al.
Investigational New Drugs|May 19, 2017
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemiaMasamichi Mori, Naoki Kaneko, Yoko Ueno, et al.
Investigational New Drugs|December 1, 1988
Toxicologic studies of a superpotent alpha-melanotropin, [Nle4, D-Phe7]alpha-MSHR T Dorr, B V Dawson, F al-Obeidi, et al.
Investigational New Drugs|May 21, 2017
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase CKhaldoun Almhanna, David Wright, Teresa Macarulla Mercade, et al.
Investigational New Drugs|June 21, 2017
Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1Zijun Zhen, Kaibin Yang, Litong Ye, et al.
Pageof 372